https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/13f-holdings-corporate-securities https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/accounts-payable https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/accrued-income-taxes-current https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/accrued-insurance-current https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/accrued-liabilities-current https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/accrued-professional-fees-current https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/accumulated-depreciation https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/acquired-deferred-tax-assets https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/additional-paid-in-capital https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/adjustments-related-to-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/amended-reports https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/aoci https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/area-of-real-estate-property https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/asset-acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/assets-fair-value-disclosure https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/auditor https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/authorized-dilution https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/available-for-sale-debt-amortized-cost-allowance-for-credit-loss-excluding-accrued-interest https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/available-for-sale-debt-amortized-cost-excluding-accrued-interest-after-allowance-for-credit-loss https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/available-for-sale-debt-excluding-accrued-interest https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/available-for-sale-debt-excluding-accrued-interest-noncurrent https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/available-for-sale-debt-unrealized-loss-position-number-of-positions https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/basic-shares https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/beta https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/borrowing-debt https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/buybacks-share-repurchases https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/buybacks-treasury-shares-acquired https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/capital-expenditures https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/capitalized-computer-software-amortization https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/cash-acquired-from-acquisition https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/cash-and-equivalents https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/cash-and-restricted-cash https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/cash-and-securities https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/cash-flow-breakdown https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/clinical-trials https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/common-stock-value https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/comprehensive-income https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/congressional-trades https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/convertible-notes-payable-current https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/convertible-securities-outstanding https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/convertible-securities-retired https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/cover-page-shares-outstanding https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/current-assets https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/current-liabilities https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/customer-breakdown https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/debt-and-obligation-disclosures https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/debt-decrease-forgiveness https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/debt-maturing-in-year-five https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/debt-maturing-in-year-four https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/debt-maturing-in-year-three https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/debt-maturing-in-year-two https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/debt-unamortized-discount https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/debt-unamortized-discount-premium-and-debt-issuance-costs-net https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/deferred-income-tax-assets-net https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/deferred-tax-assets-gross https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/deferred-tax-assets-net https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/deferred-tax-assets-other https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/defined-contribution-plan-employer-matching-contribution-percent-of-match https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/deposits https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/depreciation https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/depreciation-and-amortization https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/derivative-liabilities-current https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/diluted-shares https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/dividend-safety https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/earnings-and-revenue-growth https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/ebitda https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/effective-tax-rate https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/employee-related-liabilities-current https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/eps https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/eps-basic https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/executive-pay-measures https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/executive-pay-other https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/executive-pay-pvp https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/executive-pay-trading-arrangements https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/executive-salary-before-2006 https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/executive-salary-board https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/executive-salary-equity-awards https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/executive-salary-officers https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/executive-salary-other-compensation https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/executive-salary-other-mentions https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/executive-salary-pay-ratio https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/executive-salary-relatives https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/fails-to-deliver https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/financing-cash-flow https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/foreign-currency-exchange-rate-translation https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/foreign-pretax-income https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/free-cash-flow https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/general-and-administrative-expense https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/gross-margin https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/holders-breakdown https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/income-tax https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/income-taxes-paid https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/income-taxes-receivable https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/insider-holders https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/insider-transactions-other https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/insider-transactions-other/purchases https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/insider-transactions-preferred https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/insider-transactions-stock-options https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/insider-transactions-stock-units https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/insider-transactions-swaps-forwards-futures https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/insider-transactions-warrants https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/institutional-holders https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/interest-expense https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/interest-expense-nonoperating https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/interest-paid-net https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/interest-payable-current https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/interest-receivable-current https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/investing-cash-flow https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/investment-income-interest https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/investment-income-net-amortization-of-discount-and-premium https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/iran-activity-notices https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/late-filing-notices https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/lawsuits-defendant https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/lawsuits-plaintiff https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/lease-cost https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/lessor-operating-lease-payments-to-be-received https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/lessor-operating-lease-payments-to-be-received-five-years https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/lessor-operating-lease-payments-to-be-received-four-years https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/lessor-operating-lease-payments-to-be-received-next-twelve-months https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/lessor-operating-lease-payments-to-be-received-remainder-of-fiscal-year https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/lessor-operating-lease-payments-to-be-received-thereafter https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/lessor-operating-lease-payments-to-be-received-three-years https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/lessor-operating-lease-payments-to-be-received-two-years https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/letters-of-credit-outstanding-amount https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/loans-payable-current https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/long-term-debt https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/long-term-debt-weighted-average-interest-rate-over-time https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/major-holders https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/material-contracts https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/members-equity https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/mentioned-by-other https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/mutual-fund-holders https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/net-change-in-cash https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/net-fee-amt https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/net-income https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/news https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/number-of-businesses-acquired https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/number-of-operating-segments https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/number-of-reportable-segments https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/obligation-breakdown https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/oci-available-for-sale-adjustment-before-reclassification-adjustments-net-of-tax https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/oci-available-for-sale-adjustment-net-of-tax-2 https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/oci-available-for-sale-tax https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/oci-foreign-currency-transaction-and-translation-reclassification-adjustment-from-aoci-realized-upon-sale-or-liquidation-net-of-tax https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/oci-net-of-tax https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/operating-cash-flow https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/operating-income https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/operating-lease-assets https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/operating-lease-cost https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/operating-lease-expense https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/operating-lease-liability https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/operating-lease-liability-current https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/operating-lease-payments https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/operating-lease-payments-due https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/operating-margin https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/other https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/other-accrued-liabilities-current https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/other-current-assets https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/other-noncurrent-assets https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/other-noncurrent-liabilities https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/other-nonoperating-income-expense https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/other-operating-activities-cash-flow-statement https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/outstanding-bonds https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/outstanding-bonds-foreign https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/outstanding-bonds-matured https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/outstanding-bonds-matured-foreign https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/outstanding-bonds-matured-unclassified https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/outstanding-bonds-unclassified https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/patents https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/patents-active https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/patents-expired https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/patents-pending https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/patents-rejected https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/payables-and-obligations https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/payments-for-proceeds-from-other-investing-activities https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/payments-for-restructuring https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/payments-to-acquire-in-process-research-and-development https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/pb-ratio https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/pe-ratio https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/preferred-shares https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/preferred-shares-facts https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/preferred-stock-convertible-conversion-ratio https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/preferred-stock-dividends-per-share-declared https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/preferred-stock-shares-issued https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/preferred-stock-value https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/prepaid-insurance https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/pretax-income https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/pretax-income-domestic https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/proceeds-from-debt-net-of-issuance-costs https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/proceeds-from-stock-issued https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/property-plant-equipment https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/ps-ratio https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/public-float https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/purchase-obligation https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/purchase-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/purchase-obligation-due-in-second-and-third-year https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/purchase-obligation-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/quick-ratio https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/reclassification-from-aoci-current-period-net-of-tax-attributable-to-parent https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/reclassification-from-aoci-current-period-tax https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/reddit https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/repayments-of-debt https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/repayments-of-related-party-debt https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/research-and-development-in-process https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/restricted-cash https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/restructuring-costs https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/restructuring-reserve https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/restructuring-reserve-accrual-adjustment https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/restructuring-reserve-translation-and-other-adjustment https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/retained-earnings https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/revenue https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/sec-comment-letters https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/sec-enforcement-actions https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/sec-filings https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/share-buybacks https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/share-price https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/shareholder-equity https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/shareholders-equity https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/shares-authorized https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/shares-issued https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/shares-outstanding-analysis https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/shares-repurchased https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/short-interest https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/short-sale-volume https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/short-term-debt https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/short-term-investments https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/short-term-lease-cost https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/spending-and-interest-coverage https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-award-award-vesting-rights-percentage https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-award-percentage-of-outstanding-stock-maximum https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-based-compensation https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-issued-shares-issued-shares-espps https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-options-exercisable-number https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-options-outstanding-number https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-repurchase-program-number-of-shares-authorized-to-be-repurchased https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/stock-repurchase-program-remaining-number-of-shares-authorized-to-be-repurchased https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/sublease-income https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/subsidiaries https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/supplier-breakdown https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/tax-rate-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/tax-rate-reconciliation-nondeductible-expense-research-and-development https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/temporary-equity-shares-issued https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/total-assets https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/total-liabilities https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/total-liabilities-and-equity https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/total-long-term-debt https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/ttl-fee-amt https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/ttl-offset-amt https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/ttl-prevsly-pd-amt https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/ttl-tx-valtn https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/unrecognized-tax-benefits https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/value-added-tax-receivable https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/variable-lease-cost https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/voting-outcome https://stock.noler.com/us/stock/centessa-pharmaceuticals-plc/youtube